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ORIGINAL BASIC SCIENCE STUDIES
It is well established that both large conduit
arteries and smaller microcirculatory arteries dilate
when exposed to increases in blood flow,1-4 and this
vasodilation is dependent on an intact endotheli-
um.5,6 Endothelial cells function as mechanotrans-
ducers and respond to alterations in pressure and
flow with the paracrine release of vasoactive sub-
stances. The neighboring smooth muscle cells con-
tract or relax in response to these substances.
One important paracrine modulator of vasomo-
tor tone is nitric oxide (NO),7,8 which mediates both
acute and chronic flow-induced vasodilation.9
Increased NO production has been demonstrated in
cultured endothelial cells exposed to fluid shear stress
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in vitro.10 In addition, flow-induced arterial enlarge-
ment is inhibited by suppression of NO synthase.11
NO diffuses into the smooth muscle cells and acti-
vates soluble guanylate cyclase. This leads to increases
in cyclic guanosine monophosphate (cGMP) concen-
trations. However, the mechanisms by which increases
in cGMP lead to smooth muscle relaxation are less cer-
tain. Although some investigators have postulated that
increases in cGMP lead to decreases in intracellular
Ca2+, another mechanism by which cGMP may effect
cellular processes is through activation of cGMP-
dependent protein kinase (PKG).12 We recently
demonstrated that the NO donor, sodium nitroprus-
side, activates signaling mechanisms that lead to
increases in the phosphorylation of a small heat shock
protein, HSP20.13 We have also demonstrated that
HSP20 can be phosphorylated by PKG in vitro.13
Thus, increases in the phosphorylation of HSP20 are a
marker for activation of cyclic nucleotide-dependent
signaling processes in vascular smooth muscle.
We and other investigators have developed a
whole vessel perfusion apparatus by means of which
flow, pressure, and external vessel diameter can be
precisely measured.14-16 The effect of pressure and
flow on vasodilation in intact blood vessels was stud-
ied. We postulated that flow-induced vasodilation
would be associated with increases in the phosphory-
lation of HSP20.
MATERIALS AND METHODS
Materials. Norepinephrine (NE) and carbamyl
chloride (a stable analogue of acetylcholine [ACh])
were purchased from Sigma (St. Louis, Mo).
Electrophoresis reagents were obtained from Biorad
(Hercules, Calif), ampholines were obtained from
LKB Pharmacia (Upsalla, Sweden), 125I-protein A
was obtained from Amersham (Arlington Heights,
Ill), and Immobilon was obtained from Millipore
(Hercules, Calif). Antibodies to HSP20 were given
to us by Dr Kanefusa Kato (Aichi, Japan). All other
reagents were of analytic grade. 
Tissue harvesting. The technique for procure-
ment of bovine carotid arteries has been described
previously.16 In brief, bovine carotid arteries were har-
vested shortly after the animals were killed at an abat-
toir. Cold HEPES buffered saline solution (140
mmol/L NaCl, 4.7 mmol/L KCl, 1.0 mmol/L
MgSO4, 1.0 mmol/L NaH2PO4, 1.5 mmol/L
CaCl2, 10 mmol/L glucose, and 10 mmol/L Hepes;
pH = 7.4) was used to flush the vessels. The branch-
es were ligated under loupe magnification with 3-0
silk and 7-0 prolene suture. Vessels were then sus-
pended between the cannulas of the vasomotor per-
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fusion apparatus (VPA), taking care to maintain in
vivo length and orientation to flow. 
Whole vessel perfusion. The VPA has been
described previously.15,16 Briefly, it consists of a roller
pump (Masterflex model 7562-10, pump head 70-17-
21, Cole Palmer) that pumps oxygenated (95% O2, 5%
CO2) Krebs-bicarbonate solution (120 mmol/L
NaCl, 4.7 mmol/L KCl, 1.0 mmol/L MgSO4, 1.0
mmol/L NaH2PO4, 10 mmol/L glucose, 1.5
mmol/L CaCl2, and 25 mmol/L Na2HCO3; pH =
7.4) through the vessel.
The arteries were suspended in a chamber also
containing oxygenated Krebs-bicarbonate solution.
Intraluminal pressure was measured by means of two
transducers (Transpac, Abbott Laboratories, North
Chicago, Ill) with output to a Hewlett-Packard mon-
itor (Model 78532B). Volume flow rates of the per-
fusate were measured by means of a flow meter
(Model T108, Transonics Systems, Ithaca, NY) locat-
ed distal to the pressure transducers. Intravascular
pressure was adjusted by changing the outflow resis-
tance using a c-clamp. 
Two reservoirs at atmospheric pressure with
inflow from the vessel and outflow to the pump con-
tained oxygenated Krebs-bicarbonate solution. The
reservoirs and vessel chambers contained water jack-
ets, through which distilled water was circulated at
37°C by a thermocirculator (Cole-Palmer Polystat).
Agonists were added directly to the reservoirs.
The external diameter of the vessel was measured
by means of a helium-neon laser micrometer (Model
501-195, Laser Mike, Dayton, Ohio). Analog data
from the pressure transducers, flow meter, and
micrometer were converted to digital output via a Data
Translations DT2801 Series Board. Data was then
processed by means of a Gateway 2000 4DX2-66V PC
using LabTech Notebook Data Acquisition Software
(Laboratory Technologies, Wilmington, Mass). 
Determination of vessel viability. Vessels were
allowed to equilibrate in the VPA for one hour while
perfused with Krebs-bicarbonate solution at a flow
rate of 100 mL/min and an intravascular pressure of
20 mm Hg. The viability of each vessel was deter-
mined before subsequent experimentation. Smooth
muscle cell viability was confirmed by contractile
responses to NE (10-5 mol/L), whereas endothelial
cell viability was confirmed by vasodilation in
response to ACh (10-5 mol/L).15
Experimental protocols. The vessels were per-
fused with fresh Krebs-bicarbonate solution at 25
mL/min and 20 mm Hg intraluminal pressure for
one hour. Residual traces of NE and ACh were
washed out, and the vessels were reequilibrated to
the initial diameter. The flow rate was increased from
25 mL/min to 200 mL/min (the maximum rate of
flow that could be generated by the Masterflex
pump) in increments of 25 mL/min. After each
change in flow rate, the diameter was allowed to sta-
bilize, so that it remained unchanged for at least two
minutes. Flow was then decreased to 25 mL/min,
and 10-5 mol/L NE (the just maximal smooth mus-
cle contractile dose that produced a stable contractile
response for 90 minutes) was added to the perfusate.
The vessel was allowed to equilibrate until the diam-
eter remained unchanged for at least two minutes.
The flow rate of the perfusate was then increased
from 25 mL/min to 200 mL/min, again allowing
the diameter to stabilize and remain unchanged.
These experimental conditions were repeated for
pressures of 60 mm Hg and 100 mm Hg. 
To determine if the vasodilatation was caused by
the production of NO, the effects of the guanylate
cyclase inhibitor, methylene blue (MB, 10-3 mol/L
delivered intraluminally), on flow-induced vasodilata-
tion was determined. Arteries were precontracted
with NE (10-5 mol/L), and MB was added to the
perfusate. Flow was increased in increments from 25
mL/min to 200 mL/min, and the vessel diameter
was measured as described.
HSP20 phosphorylation. Phosphorylation of
HSP20 is associated with a shift of the protein from
more basic nonphosphorylated isoforms to multiple
phosphorylated isoforms.13 With this property and a
highly specific affinity purified polyclonal antibody
against HSP20,17 we performed isoelectric focusing
immunoblots. Bovine carotid arteries were equilibrat-
ed in the presence of NE (10-5 mol/L), a pressure of
20 mm Hg, and a flow of 100 mL/min. The flow was
then increased to 200 mL/min for five minutes (con-
ditions in which maximal flow-induced vasodilation
occurred). As a positive control of endothelial-depen-
dent NO production, vessels were precontracted with
NE (10-5 mol/L) and relaxed with ACh (10-5
mol/L). The vessels were snap frozen in liquid nitro-
gen and ground to a fine powder. The powder was
placed in acetone, trichloroacetic acid (TCA, 10%),
dithiothreotol (DTT, 100 mmol/L) solution, frozen
in liquid nitrogen again, and allowed to come to room
temperature. The TCA was removed by washing three
times in acetone/DTT, and the samples were speed
evaporated. The powder was reconstituted in urea (9
mol/L), chaps (2%), DTT (100 mmol/L), and pro-
tein weighted with the Coomassie Plus Protein Assay
Reagent (Pierce, Rockford, Ill). Protein (30 m g) was
loaded into each well of an isoelectric focusing slab gel
containing Ampholines (pH 4-6, 6-8, 1:1). The pro-
teins were focused for one hour at 100 V, one hour at
200 V, and 75 minutes at 500 V. Initial experiments
were performed, in which the proteins were then sep-
arated by relative mobility with sodium dodecyl sul-
fate-polyacrylamide gel electrophoresis gels (10%) and
transferred to Immobilon for 210 volt hours. In sub-
sequent experiments for quantitative data, the isoelec-
tric focusing gels were transferred directly to
Immobilon for 210 volt hours. The blot was air dried
and subsequently blocked with tris buffered saline
(TBS: 10 mmol/L Tris, 150 mmol/L NaCl; pH =
7.4)/ 5% milk for one hour. The blots were then incu-
bated with anti-HSP20 antibodies (1:5000) in
TBS/milk for one hour at room temperature. The
blots were washed three times (five minutes each) 
in TBS/Tween-20 (0.5%). Immunoreactive protein 
was determined using 125I-protein A (1:1000 dilu-
tion). The blots were again washed six times (five min-
utes each) in TBS/Tween-20. The blots were then
exposed on a PhosphorImager (Molecular Dynamics,
Sunnyvale, Calif) screen for 18 hours.
Data analysis. Flow-dependent changes in ves-
sel diameter (D D) were calculated as a normalized
value. The initial diameter (Dinitial) for a vessel was
measured at a flow rate of 25 mL/min in the pres-
ence or absence of 10-5 mol/L NE for pressures of
20, 60, or 100 mm Hg. D D was defined as:
D D = [(Dfinal – Dinitial )/Dinitial] · 100
Results were reported as the mean ± standard
error of the mean. For comparisons between two
groups of data, the unpaired t test was used. For
comparison of more than two groups, one 
way analysis of variance (ANOVA) was used. A P
value less than .05 was considered significant.
Densitometric analysis of PhosphorImager data was
performed by means of Imagequant software
(Molecular Dynamics, Sunnyvale, Calif).
RESULTS
Vessel viability. All vessels contracted in response
to NE (10-5 mol/L, 28% ± 2% decrease in initial arte-
rial diameter). The subsequent addition of ACh (10-5
mol/L) to vessels precontracted with NE (10-5
mol/L) resulted in vasodilation to 97% ± 1% of the
initial resting diameter. The vessels that contracted in
response to NE and subsequently relaxed in response
to ACh were reequilibrated and used in subsequent
experiments.
Influence of pressure, flow, and norepineph-
rine on vessel diameter. Flow-dependent changes
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in vessel diameter were measured relative to the ini-
tial diameter at a flow rate of 25 mL/min. At 20 mm
Hg pressure, increasing the flow rates from 40 to
200 mL/min significantly increased the vessel diam-
eter (Fig 1). There were no significant flow-induced
increases in diameter at 60 mm Hg pressure or at 100
mm Hg (Fig 1). The flow-induced changes at low
(20 mm Hg) pressure were biphasic in the presence
of NE (10-5 mol/L). At flow rates of 50 and 100
mL/min, there was a significant decrease in vessel
diameter, and at flow rates greater than 175
mL/min, the vessel diameter significantly increased
(Fig 2). At 60 mm Hg pressure in the presence of NE
(10-5 mol/L), increases in flow led to decreases in
vessel diameter at flows of 100 and 120 mL/min
(Fig 2). Increases in flow rates in the presence of NE
(10-5 mol/L) at pressures of 100 mm Hg did not
lead to changes in vessel diameter (Fig 2). Thus,
maximal flow induced vasodilatation occurred at a
flow rate of 200 mL/min, an intraluminal pressure of
20 mm Hg, and in the presence of NE (Fig 2). The
flow-induced vasodilatation under these maximal
conditions was completely inhibited in the presence
of MB (10-3 mol/L; Fig 3). Finally, flow-induced
vasodilatation under these maximal conditions was
similar to the extent of vasodilatation associated with
ACh stimulation (24.9% ± 1.5% vs 30.2% ± 4.8%
dilatation, respectively).
Fig 1. The effect of pressure on flow-dependent vasodila-
tion. Flow-dependent changes in vessel diameter (D D)
were examined at pressures of 20, 60, and 100 mm Hg. At
intraluminal pressures of 20 mm Hg (closed circles), there
were significant increases in vessel diameter when the flow
was increased from 25 mL/min to 50 to 200 mL/min (P
< .05, compared with the diameter at 25 mL/min, Student
t test, n = 8). There were no significant increases in vessel
diameter to increases in flow at pressures of 60 mm Hg
(open circles) or 100 mm Hg (closed triangles).
Fig 2. The effect of norepinephrine on flow-dependent
vasodilation. A, Flow-induced changes in vessel diameter
in the presence of norepinephrine (NE, 10-5 mol/L [open
circles]) at 20 mm Hg, compared with changes in the
absence of norepinephrine (closed circles), were biphasic. B,
There was an initial decrease in vessel diameter at low flow
rates (50 and 75 mL/min), and an increase in vessel diam-
eter at higher flow rates (175 and 200 mL/min; P < .05
+NE, compared with –NE, Student t test, n = 8). Increases
in flow in the presence of norepinephrine (10-5 mol/L
[open circles]) at 60 mm Hg led to decreases in the vessel
diameter at flows of 100 and 125 mL/min (P < .05 +NE
[open circles], compared with –NE [closed circles], Student
t test, n = 8). C, There were no changes in vessel diameter
to increased flow rates in the presence of norepinephrine
(10-5 mol/L [open circles]) at 100 mm Hg pressure.
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Shear stress. Shear stress (dyne/cm2) was cal-
culated by means of a modification of the Hagen-
Poiseuille formula:
t = 4m Q/p r3
where t is shear, m is the viscosity of water (0.007
poise), Q is volume flow rate (mL/min), and r is the
external radius of the vessel. At a flow of 100
mL/min, the calculated shear stress was 1.3 ± 0.2
dyne/cm2, and immediately after the flow was
increased to 200 mL/min, there was a significant
increase in shear stress to 2.5 ± 0.2 dyne/cm2 (n =
4, P < .05 by means of the Student t test). Five min-
utes after the flow was increased to 200 mL/min,
the vessel diameter had increased and the shear stress
had returned to 1.4 ± 0.2, a level that was not sig-
nificantly greater than the shear stress at 100
mL/min. These shear stresses are lower than most
physiologic shear stresses (5 to 10 dyne/cm2); how-
ever, the increase in flow from 100 to 200 mL/min
did lead to significant increases in shear stress. In
addition, these shear stresses are similar to those
produced in other animal models.18
Phosphorylation of HSP20. In a separate
series of experiments, increases in flow (at 20
mmol/L Hg, + NE 10-5 mol/L) from 100 mL/min
to 200 mL/min led to 25.0% ± 1.5% increase in the
diameter of the vessel. This vasodilation was associ-
ated with increases in the amount of the phosphory-
lated isoform of HSP20 (Fig 4). This increase in
phosphorylation was quantitated by means of iso-
electric focusing immunoblots (Fig 5). The extent of
the increase in HSP20 phosphorylation induced by
means of increases in flow was similar to the increase
in phosphorylation that occurred with ACh stimula-
tion. There was no increase in HSP20 phosphoryla-
tion in response to ACh or flow in the presence of
MB (n = 3; data not shown). MB did not directly
inhibit HSP20 phosphorylation (27.0% ± 5.0%
increase in phosphorylation of the most acidic iso-
form; n = 3) in strips of carotid artery stimulated
with isobutyl methylxanthine (1 mmol/L, a phos-
phodiesterase inhibitor) and forskolin (10 m mol/L,
an adenylate cyclase activator).
DISCUSSION
The vasomotor responses to increases in flow in
intact bovine carotid arteries perfused ex vivo are
dependent on the intraluminal pressure. At low
intraluminal pressures (20 mm Hg), there was flow-
induced vasodilation. However, at higher pressures
(60 and 100 mm Hg), there was no significant
vasodilation in response to increases in flow. Other
investigators have also demonstrated that flow-
dependent vasodilatation is greater at lower intralu-
minal pressures.19
When the vessels were precontracted with NE,
the response to increases in flow at low intraluminal
pressures (20 mm Hg) was biphasic. After increases
in flow from 25 to 100 mL/min, there was mild
vasoconstriction. When flow rates were increased to
175 to 200 mL/min, there was marked vasodilation.
This maximal flow-dependent vasodilation was com-
pletely inhibited by MB. Although the precise mech-
anisms of action of MB are not known, MB is
thought to inhibit gyanylate cyclase or endothelium-
derived vasodilators, such as NO or prostacy-
clin.20,21 The inhibition of the flow-induced vasodi-
lation by MB suggests that the vasodilation is medi-
ated by the paracrine release of endothelial-derived
relaxation factors. 
At intraluminal pressures of 60 mm Hg, increas-
es in flow led to vasoconstriction. High intraluminal
pressures may block the synthesis of NO, the release
of NO, or both.19 In addition, it is possible that
increases in flow at higher pressures led to endothe-
lial-dependent release of vasoconstricting sub-
stances, such as endothelin. Increased intraluminal
pressure may also alter smooth muscle responses. At
higher intraluminal pressures, the smooth muscle
may not be able to generate sufficient force to
change the diameter of the vessel. Taken together,
these data suggest that vascular responses to increas-
Fig 3. Methylene blue inhibited flow-induced vasodila-
tion. The maximal flow-induced changes in vessel diame-
ter at pressures of 20 mm Hg in the presence of norepi-
nephrine (10-5 mol/L [open circles]) were inhibited by
methylene blue (10 -3 mol/L [closed circles], P < .05,
Student t test, n = 4).
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es in flow are dependent on the intrinsic tone of the
vessel and on the intraluminal pressure.
In vessels precontracted with NE, stimulation
with ACh led to increases in diameter similar to
those that occurred with maximal increases in flow.
ACh leads to vasorelaxation via endothelial produc-
tion of NO.7,8 Both ACh treatment and flow-
induced vasodilation were associated with increases
in the phosphorylation of the small heat shock pro-
tein HSP20. This suggests that endothelial-depen-
dent vasodilation is associated with increases in the
phosphorylation of HSP20. 
Increases in the phosphorylation of HSP20 have
been associated with either cAMP monophosphate-
dependent or cGMP-dependent vasorelaxation.13 In
addition, HSP20 is not phosphorylated in umbilical
artery smooth muscle, a muscle that is uniquely
refractory to cyclic nucleotide-dependent vasorelax-
ation.22,23 The small heat shock proteins HSP20 and
HSP27 are highly expressed in muscle and may play
a role in modulating contractile responses. HSP27
has been implicated in bombesin-induced contrac-
tion of rectal sphincter smooth muscle,24 and
increases in the phosphorylation of HSP27 are asso-
ciated with thrombin-induced contraction of vascu-
lar smooth muscle.25 The small heat shock proteins
have been implicated in modulating actin filament
dynamics and intermediate filament polymerization.
Recently, we determined that HSP20 is an actin-
associated protein in vitro and that the association
with actin is dependent on the phosphorylation state
of HSP20.26 It is possible that the functions of the
small heat shock proteins are interrelated, and they
may alter contractile states by directly chaperoning
the contractile apparatus.
Fig 4. HSP20 phosphorylation. This representative two-dimensional immunoblot demon-
strates increases in a more acidic isoform of HSP20 (arrow) when the flow was increased from
100 mL/min (NE100) to 200 mL/min (NE200), in the presence of norepinephrine (10-5
mol/L) and at low intraluminal pressures (20 mm Hg). There were also increases in the acidic
isoform of HSP20 in vessels that had been precontracted with norepinephrine (10-5 mol/L)
and then treated with acetylcholine (10-5 mol/L, NEACh). The relative mobility is indicated
on the left panel, and the isoelectric focusing gradient is indicated on the top of each panel.
Fig 5. Quantitative analysis of HSP20 phosphorylation.
Vessels were precontracted with norepinephrine (10-5
mol/L), and then either the flow was increased from 100 to
200 mL/min (NE200) or the vessels were treated with
acetylcholine (10-5 mol/L, NEACh). Activation of endothe-
lial cells with either increased flow or with acetylcholine led
to significant increases in the phosphorylated isoform of
HSP20, compared with low flow (NE100), as determined
by means of quantitative analysis of isoelectric focusing
immunoblots (* =P < .05, analysis of variance, n = 4).
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In summary, the responses of isolated perfused
bovine carotid arteries to increases in flow were
dependent on the intrinsic tone of the vessel and the
intraluminal pressure. Flow-mediated vasodilation
was significantly greater at low intraluminal pres-
sures and in vessels that were precontracted with
NE. At higher intraluminal pressures, increases in
flow in vessels precontracted with NE led to vaso-
constriction. Flow-induced vasodilation and ACh
stimulation were associated with increases in the
phosphorylation of HSP20. Thus, the paracrine
release of vasorelaxing substances from the endothe-
lium may be associated with increases in the phos-
phorylation of HSP20. HSP20 may be a down-
stream signaling modulator of vasorelaxation.
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